Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03530059
Other study ID # 38RC17.300
Secondary ID 2017-A02697-46
Status Completed
Phase
First received
Last updated
Start date February 9, 2018
Est. completion date July 21, 2019

Study information

Verified date November 2019
Source University Hospital, Grenoble
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is a prospective observational study which aim to evaluate the feasibility of a total and systematic home respiratory rehabilitation training program in patients who will undergo thoracic surgery, and otherwise tend to define failure reasons.


Description:

The aim of this clinical trial is to identify the determining factors which impact a preoperative home respiratory rehabilitation training program success. This success is determined by complete achievement of the program (100%) by the patient.

This rehabilitation program is composed by 4 items:

- Adapted physical activity : 3 averaging cyclo ergometer or physical activity seances per week (25%)

- Physiotherapy sessions : 8 seances with a physical therapist (25%)

- Smokers : Set up of a program to help give up smoking if active smoker (25%)

- Dietetics : If unintentionally weight loss (>5% total weight in 1 month or >10% in 6 months) or BMI<21 , nutritional assessment is conducted and dietetic program is initiated(25%)

Secondary objectives are :

- Assessment of postoperative event onset (30 days) (atelectasis, fibro-aspiration, time spent in resuscitation unit, intubation, revision surgery).

- Link assessment of 100% program success and at least one complication onset.

- Cost assessment of preoperative rehabilitation program

- Evaluation of mean hospitalisation duration post surgery (30 days)

- Average cost assessment of hospitalisation stay per patient.

This study will include 50 patients over 18 years old, addressed to the home heath care provider AGIR à Dom, for rehabilitation before pulmonary parenchyma exeresis.

Patients must perform at least 2 items of rehabilitation program previously described.

This program is an initiative of a pulmonologist or a thoracic surgeon, who include the patient when the date of surgery is scheduled.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date July 21, 2019
Est. primary completion date June 21, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who need a respiratory rehabilitation before thoracic surgery for lung resection.

- Patients addressed to the home heath care provider "AGIR à Dom",

- Patients must perform at least 2 items of rehabilitation program (Adapted physical activity, Diet, Physiologist, Smoking)

Exclusion Criteria:

- Patients who participate to another interventional research that may impact this study.

- Patients unable to get involved to the training program, depending to the investigator's appreciation.

Study Design


Intervention

Other:
Home-based rehabilitation
Observational study

Locations

Country Name City State
France Maison Medicale Des Cedres Echirolles
France Chu Grenoble Alpes Grenoble
France GROUPE HOSPITALIER MUTUALISTE INSTITUT de CANCEROLOGIE DANIEL HOLLARD Grenoble
France Centre Medivallee Saint-Ismier ZI La Batie 35 Allée Du Champrond
France Cabinet de Chirurgie Cardio Vasculaire Saint-Martin-d'Hères

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Completion (yes/no) of the home-training program based on 4 items: tobacco, dietary, physical activity and physiotherapy before thoracic surgery Completion (yes/no) of the home-training program based on 4 items: tobacco, dietary, physical activity and physiotherapy before thoracic surgery :
Tobacco: measure of tobacco consumption (self-report)
Dietary: body mass
Physical activity: number of physical activity sessions
Physiotherapy: number of physical therapy sessions
from date of inclusion until the end of hospitalisation for thoracic surgery, assessed up to 6 months
Secondary Post operative event number Post operative event number 30 days
Secondary Rehabilitation program costs Rehabilitation program costs before surgery for the 4 program rehabilitation items from date of inclusion until the beginning of hospitalisation for thoracic surgery, assessed up to 6 months
Secondary Hospitalisation duration Hospitalisation duration in days per unit from the beginning until the end of hospitalisation for thoracic surgery, assessed up to 3 months
Secondary Total hospitalisation cost Total hospitalisation cost per patient = sum for all unit from the beginning until the end of hospitalisation for thoracic surgery, assessed up to 3 months
See also
  Status Clinical Trial Phase
Completed NCT03918538 - A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors N/A
Recruiting NCT05078918 - Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors N/A
Active, not recruiting NCT04548830 - Safety of Lung Cryobiopsy in People With Cancer Phase 2
Completed NCT04633850 - Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Not yet recruiting NCT06376253 - A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers Phase 1
Recruiting NCT05898594 - Lung Cancer Screening in High-risk Black Women N/A
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT03667716 - COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Phase 1
Active, not recruiting NCT03575793 - A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Terminated NCT03275688 - NanoSpectrometer Biomarker Discovery and Confirmation Study
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Recruiting NCT06010862 - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Phase 1
Recruiting NCT06052449 - Assessing Social Determinants of Health to Increase Cancer Screening N/A
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk